These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2511706)
1. [The isolation and immunologic study of ribosomal preparations from Shigella flexneri]. Belkin ZP; Egorova TP; Fedosova VG; Balaeva EIa; Lebenson VI Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):28-33. PubMed ID: 2511706 [TBL] [Abstract][Full Text] [Related]
2. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants]. Levenson VI; Rukhadze EZ; Belkin ZP; Essaulova ME Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):55-9. PubMed ID: 2464261 [TBL] [Abstract][Full Text] [Related]
3. [Biological properties of a ribosomal vaccine from S. sonnei obtained by polyethylene glycol fractionation]. Levenson VI; Rukhadze EZ; Fedosova VG; Dzhikidze EK; Stasilevich ZK Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):77-81. PubMed ID: 6395593 [TBL] [Abstract][Full Text] [Related]
11. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection. Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735 [TBL] [Abstract][Full Text] [Related]
12. Parenteral immunization with Shigella ribosomal vaccine elicits local IgA response and primes for mucosal memory. Levenson VI; Chernokhvostova EV; Lyubinskaya MM; Salamatova SA; Dzhikidze EK; Stasilevitch ZK Int Arch Allergy Appl Immunol; 1988; 87(1):25-31. PubMed ID: 3049397 [TBL] [Abstract][Full Text] [Related]
13. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes. Verma NK; Lindberg AA Vaccine; 1991 Jan; 9(1):6-9. PubMed ID: 2008803 [TBL] [Abstract][Full Text] [Related]
14. Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains. Hartman AB; Powell CJ; Schultz CL; Oaks EV; Eckels KH Infect Immun; 1991 Nov; 59(11):4075-83. PubMed ID: 1937767 [TBL] [Abstract][Full Text] [Related]
15. Polysaccharide nature of O antigen in protective ribosomal preparations from Shigella: experimental evidence and implications for the ribosomal vaccine concept. Levenson VI; Egorova TP Res Microbiol; 1990; 141(6):707-20. PubMed ID: 1704638 [TBL] [Abstract][Full Text] [Related]
16. [Ribosomal dysentery vaccine. II. Biological trials of active protection for guinea pigs and mice]. Levinson VI; Subbotina IuL Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):81-6. PubMed ID: 358702 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine. DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253 [TBL] [Abstract][Full Text] [Related]
18. Protective milk O antibodies induced in guinea pigs by parenteral Shigella ribosomal vaccine. Chernokhvostova EV; Lyubinskaya MM; Belkin ZP; Levenson VI Int Arch Allergy Appl Immunol; 1990; 92(3):265-7. PubMed ID: 2276843 [TBL] [Abstract][Full Text] [Related]
19. [Ribosomal dysentery vaccine. III. An immunochemical and serological study]. Subbotina IuL; Levenson VI; Gofman IL Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):44-52. PubMed ID: 110015 [TBL] [Abstract][Full Text] [Related]
20. [Isotypic characteristics of serum and secretory O antibodies and local immunological memory in the parenteral immunization of guinea pigs with a ribosomal Shigella vaccine]. Liubinskaia MM; Chernokhvostova EV; Levenson VI Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):36-40. PubMed ID: 3284254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]